Commentary by Rachana Jani MD, PGY-1 and Neal Steigbigel MD, Professor of Medicine (Infectious Diseases/Immunology)
Rachana Jani MD: Â Walking onto an oncology floor, one cannot help but notice the precautionary signs that segregate …
Category: Heme/Onc
Clinical Correlations
Future Medicine: The Search for a New Anticoagulant
April 16, 2008
Future Medicine is a new section of Clinical Correlations devoted to hot areas of research and development in various fields of medicine. In tihis series, we will highlight treatments in their infancy, from basic research opening …
Mystery Quiz- The Answer
February 6, 2008Posted By: Vivian Hayashi, MD, Instructor of Clinical Medicine, Division of General Internal Medicine and Robert Smith, MD Associate Professor of Medicine, Division Pulmonary and Critical Care Medicine
The answer to the mystery quiz is lung cancer, in particular, adenocarcinoma with a predominantly bronchoalveolar cell pattern (BAC). The clue to the mystery was …
Grand Rounds: Breast Cancer Genomics
November 20, 2007
Commentary by Jonathan Willner MD, PGY-2
This week’s Medicine Grand Rounds speaker was Lisa Carey, MD, Associate Professor in Hematology/Oncology at the University of North Carolina and Medical Director of the …
Grand Rounds: “Towards Biologically Rational Therapy for Myelodysplastic Sydrome.â€
November 2, 2007Welcome to our new Grand Rounds Series. Each week, we plan to post a summary of the week’s Medicine Grand Rounds lecture. The summaries are reviewed and approved by the grand …
Elevated Total Protein and the Interpretation of Serum Protein Electrophoresis
November 1, 2007Commentary by Jamie Hoffman, MDÂ
A healthy 54 year old man without past medical history presents for a routine physical exam for his insurance company. His blood work reveals a total protein (TP) of 9.4 g/dl and an albumin of 3.0 g/dl. What should be included in this patient’s diagnostic workup?
Tumor Lysis Syndrome and the Role of Urinary Alkalinization
September 13, 2007
Commentary by Bani Chander MD, PGY-2, and Sergio Obligado MD, Attending Physician, Nephrology
Tumor lysis syndrome (TLS) is characterized by a group of metabolic abnormalities including hyperkalemia, hyperuricemia, and hyperphosphatemia with secondary …
How do you assess a patient’s risk for recurrent DVT?
July 6, 2007
Commentary by Sean Cavanaugh MD, Associate Editor, Clinical Correlations
A 51-year-old man with a history of DVT diagnosed seven months ago presents to your clinic for follow up. He has no family history of blood clots. He …